Walpar Nutritions Limited, initially established as 'M/s Walpar Healthcare' in 2009, transitioned from a partnership firm to a public limited company in December 2020. The company specializes in the manufacturing, marketing, and trading of pharmaceuticals, nutraceuticals, herbal, and Ayurvedic products both online and offline. It holds FSSAI and AYUSH licenses, allowing it to produce a range of products, including tablets, capsules, oral liquids, and external preparations. With a history of strategic expansion, the company moved its manufacturing facilities to Santej, Gandhinagar, and enhanced its production capabilities over the years.
In July 2021, Walpar Nutritions raised Rs. 6.60 Crore through a public issue of equity shares. The company has also expanded its market reach by exporting products to multiple countries. It has invested in research and development, including establishing an online platform for B2C pharmaceutical raw material supply, and launched customized nutrition solutions under the MI supplement division.
